Securities code: 688360 securities abbreviation: Zhejiang Damon Technology Co.Ltd(688360) Announcement No.: 2022-001 Zhejiang Damon Technology Co.Ltd(688360) Group Co., Ltd
Announcement on the death of core technicians
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal liabilities for the authenticity, accuracy and integrity of its contents according to law.
Important content tips:
Mr. Ma Xianxiang, the core technician of Zhejiang Damon Technology Co.Ltd(688360) Group Co., Ltd. (hereinafter referred to as “the company”), died of illness and no longer served as the president of the Logistics Technology Research Institute of the company.
After Mr. Ma Xianxiang’s death, it will not affect the company’s technology R & D, production and operation, and the company’s core technology and R & D work.
1、 Details of core technicians
Mr. Ma Xianxiang, the company’s core technician, died of illness and no longer served as the president of the company’s logistics technology research institute. Mr. Ma Xianxiang has been in the company for more than ten years. During his tenure, he loves his post and is dedicated, scrupulous, diligent and responsible, and has made outstanding contributions to the operation and development of the company. The board of directors of the company deeply thanks Mr. Ma Xianxiang for his efforts and contributions to the company!
Mr. Ma Xianxiang joined the company in 2003. Before his death, he served as the president of the Logistics Technology Research Institute of the company and was the core technician of the company. As of the disclosure date of this announcement, Mr. Ma Xianxiang did not directly hold the shares of the company, and he indirectly held 0.2657% of the shares of the company through the employee stock ownership platform.
2、 Impact of the death of core technicians on the company
(i) R & D projects and patents participated by core technicians
At present, the company is mainly engaged in research projects, and Mr. Ma Xianxiang has not directly participated in relevant R & D work. The death of Mr. Ma Xianxiang will not affect the promotion and implementation of the company’s main research projects.
During his tenure, Mr. Ma Xianxiang formed relevant patents as a non single inventor. The patent owner or applicant is the company or a wholly-owned subsidiary of the company. There is no case of applying for and obtaining patents as a single inventor. The death of Mr. Ma Xianxiang does not affect the integrity of the company’s patent right.
（2） Core R & D personnel of the company
The company attaches great importance to R & D, and the R & D team structure and echelon are complete. As of June 30, 2021, the number of R & D personnel of the company is 210, accounting for 19.63% of the total number of employees. At present, the company’s production, operation and technology R & D are carried out normally.
As of the disclosure date of this announcement, the changes of the company’s core technical personnel are as follows:
Name of key technical personnel during the period
Before this change, Ma Xianxiang, Tang Xiaoming, Zhu Minqi, Lin Zhaoqi and Dai Guohua
After this change, Tang Xiaoming, Zhu Minqi, Lin Zhaoqi and Dai Guohua
3、 Measures taken by the company
At present, the company’s R & D team structure and echelon are complete, and the company’s R & D projects are in a normal and orderly state; The company’s existing R & D team and core technical personnel can support the R & D of the company’s core technology. Subsequently, the company will further increase the introduction and training of high-end and professional technicians, continue to increase R & D investment, and continuously improve the company’s R & D and continuous innovation ability.
4、 Verification opinions of the recommendation institution
After verification, the sponsor believes that the death of Mr. Ma Xianxiang will not affect the promotion and implementation of the company’s main research projects and the integrity of the company’s patent right; The company’s R & D team and core technical personnel are relatively stable. The death of Mr. Ma Xianxiang will not have a significant adverse impact on the company’s R & D strength and the company’s sustainable operation ability.
It is hereby announced.
Board of directors of Zhejiang Damon Technology Co.Ltd(688360) Group Co., Ltd. January 4, 2022
